Systemic Delivery of mPEG‐Masked Trispecific T‐Cell Nanoengagers in Synergy with STING Agonists Overcomes Immunotherapy Resistance in TNBC and Generates a Vaccination Effect
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systemic Delivery of mPEG‐Masked Trispecific T‐Cell Nanoengagers in Synergy with STING Agonists Overcomes Immunotherapy Resistance in TNBC and Generates a Vaccination Effect
Authors
Keywords
-
Journal
Advanced Science
Volume -, Issue -, Pages 2203523
Publisher
Wiley
Online
2022-09-12
DOI
10.1002/advs.202203523
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A tumor microenvironment-responsive poly(amidoamine) dendrimer nanoplatform for hypoxia-responsive chemo/chemodynamic therapy
- (2022) Yingchao Hao et al. JOURNAL OF NANOBIOTECHNOLOGY
- Strategies of engineering nanomedicines for tumor retention
- (2022) Xindi Qian et al. JOURNAL OF CONTROLLED RELEASE
- Turning cold tumors hot: from molecular mechanisms to clinical applications
- (2022) Jiahui Zhang et al. TRENDS IN IMMUNOLOGY
- Interferons in cancer immunoediting: sculpting metastasis and immunotherapy response
- (2021) Michelle von Locquenghien et al. JOURNAL OF CLINICAL INVESTIGATION
- CD276 expression enables squamous cell carcinoma stem cells to evade immune surveillance
- (2021) Cheng Wang et al. Cell Stem Cell
- PD-L1 tumor-intrinsic signaling and its therapeutic implication in triple-negative breast cancer
- (2021) Chunhua Chen et al. JCI Insight
- Harnessing Innate Immunity Using Biomaterials for Cancer Immunotherapy
- (2021) DaeYong Lee et al. ADVANCED MATERIALS
- The state of the art of bispecific antibodies for treating human malignancies
- (2021) Shuhang Wang et al. EMBO Molecular Medicine
- Cancer stem cells in TNBC
- (2021) Zhan Hua et al. SEMINARS IN CANCER BIOLOGY
- Progress and challenges of immunotherapy in triple-negative breast cancer
- (2021) Yinxing Zhu et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Fasting-mimicking diet blocks triple-negative breast cancer and cancer stem cell escape
- (2021) Giulia Salvadori et al. Cell Metabolism
- Treatment landscape of triple-negative breast cancer — expanded options, evolving needs
- (2021) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- Next generation of tumor-activating type I IFN enhances anti-tumor immune responses to overcome therapy resistance
- (2021) Xuezhi Cao et al. Nature Communications
- Tumor‐Microenvironment‐Responsive Nanomedicine for Enhanced Cancer Immunotherapy
- (2021) Shaojun Peng et al. Advanced Science
- PD-L1 is overexpressed on breast cancer stem cells through notch3/mTOR axis
- (2020) Fatmah A. Mansour et al. OncoImmunology
- Challenges and strategies for next-generation bispecific antibody-based antitumor therapeutics
- (2020) Heliang Li et al. Cellular & Molecular Immunology
- Role of Immunotherapy in Triple-Negative Breast Cancer
- (2020) Tanya E. Keenan et al. Journal of the National Comprehensive Cancer Network
- T cell-engaging therapies — BiTEs and beyond
- (2020) Maria-Elisabeth Goebeler et al. Nature Reviews Clinical Oncology
- NPM1 upregulates the transcription of PD-L1 and suppresses T cell activity in triple-negative breast cancer
- (2020) Ge Qin et al. Nature Communications
- Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers
- (2020) Jun Fang et al. ADVANCED DRUG DELIVERY REVIEWS
- Tumour sensitization via the extended intratumoural release of a STING agonist and camptothecin from a self-assembled hydrogel
- (2020) Feihu Wang et al. Nature Biomedical Engineering
- T Cell-Engaging Therapy for Solid Tumors
- (2020) Maria de Miguel et al. CLINICAL CANCER RESEARCH
- cGAS-STING pathway in cancer biotherapy
- (2020) Yang Wang et al. Molecular Cancer
- Engineering Prodrug Nanomedicine for Cancer Immunotherapy
- (2020) Bin Yang et al. Advanced Science
- Enhancing anti-tumour efficacy with immunotherapy combinations
- (2020) Funda Meric-Bernstam et al. LANCET
- Engineering precision nanoparticles for drug delivery
- (2020) Michael J. Mitchell et al. NATURE REVIEWS DRUG DISCOVERY
- The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment
- (2020) Muyue Yang et al. Bioactive Materials
- Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy
- (2019) Anping Li et al. Journal of Hematology & Oncology
- Cancer stemness, intratumoral heterogeneity, and immune response across cancers
- (2019) Alex Miranda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bispecific antibodies: a mechanistic review of the pipeline
- (2019) Aran F. Labrijn et al. NATURE REVIEWS DRUG DISCOVERY
- Targeting Cancer Stem Cells in Triple-Negative Breast Cancer
- (2019) Park et al. Cancers
- Cancer stem cells and their unique role in metastatic spread
- (2019) Teresa Bernadette Steinbichler et al. SEMINARS IN CANCER BIOLOGY
- CD44 promotes PD-L1 expression and its tumor-intrinsic function in breast and lung cancers
- (2019) Tim Kong et al. CANCER RESEARCH
- Hyaluronan-CD44 axis orchestrates cancer stem cell functions
- (2019) Spyros S. Skandalis et al. CELLULAR SIGNALLING
- STING: a master regulator in the cancer-immunity cycle
- (2019) Yuanyuan Zhu et al. Molecular Cancer
- Intratumor Performance and Therapeutic Efficacy of PAMAM Dendrimers Carried by Clustered Nanoparticles
- (2019) Hong-Jun Li et al. NANO LETTERS
- Harnessing innate immunity in cancer therapy
- (2019) Olivier Demaria et al. NATURE
- Bispecific antibody based therapeutics: Strengths and challenges
- (2018) Archana Thakur et al. BLOOD REVIEWS
- Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy
- (2018) Minan Wang et al. FASEB JOURNAL
- STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion
- (2018) Jung-Mao Hsu et al. Nature Communications
- Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune Evasion
- (2018) Peixin Dong et al. Frontiers in Oncology
- Interferon-beta represses cancer stem cell properties in triple-negative breast cancer
- (2017) Mary R. Doherty et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The cytotoxic T lymphocyte immune synapse at a glance
- (2016) Nele M. G. Dieckmann et al. JOURNAL OF CELL SCIENCE
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- Biophysical Aspects of T Lymphocyte Activation at the Immune Synapse
- (2016) Claire Hivroz et al. Frontiers in Immunology
- Multifunctional Tumor pH-Sensitive Self-Assembled Nanoparticles for Bimodal Imaging and Treatment of Resistant Heterogeneous Tumors
- (2014) Daishun Ling et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- The immune synapse clears and excludes molecules above a size threshold
- (2014) Adam N. R. Cartwright et al. Nature Communications
- The Immunological Synapse
- (2014) M. L. Dustin Cancer Immunology Research
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More